Serum Iron, Serum Ferritin and Hepatic Iron Content as a Predictive Values for Combined Therapy of Chronic Hepatitis C Patients

Serum Hepcidin In Patients With Chronic Hepatitis C And Its Relation To Treatment With Antiviral Drugs

Ceruloplasmin as a Predictor for Responsiveness to Direct Antiviral Drugs in Treatment of Chronic HCV Infection

Monitoring Hepcidin Level in Chronic Hepatitis C Virus Patients during Therapy

A Key Regulator For Iron Homeostasis in chronic hepatitis C.

The Value of Iron Metabolism Dynamic Changes in Response to Direct Anti-Viral Agents among Egyptian Chronic HCV Patients

Can Serum Iron Parameters Represent Surrogate Markers for Chronic Hepatitis C-Based Hepatocellular Carcinoma?

Molecular study of hepcidin in chronic hepatitis C genotype 4 patients treated with pegylated interferon/ribavirin with vitamin D

Do Sofosbuvir and Daclatasvir Affect Vitamin D and Iron Status in Chronic Hepatitis C Virus Patients? Role of Hepcidin

Liver Fibrosis as a Predictive Factor of Response to Pegylated-IFN/ Ribavirin Therapy in Chronic HCV Patients